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ABSTRACT  
Gametocyte density and sex-ratio can predict the proportion of mosquitoes that become infected 
after feeding on blood of patients receiving non-gametocytocidal drugs. Because primaquine and 
methylene blue sterilize gametocytes before affecting their density and sex-ratio, mosquito feeding 
experiments are required to demonstrate their early transmission-blocking effects. 
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INTRODUCTION 
Transmission of malaria depends on mature sexual stage parasites (gametocytes) in the peripheral 
blood. Blood-feeding Anopheles mosquitoes must ingest at least one male and one female 
gametocyte to become infected. The formation of Plasmodium oocysts on the mosquito midgut wall 
is commonly used as evidence for successful transmission; these oocysts enlarge over time to 
rupture and release sporozoites that render mosquitoes infectious. In absence of treatment, 
infectivity of malaria-infected individuals can be reasonably well predicted by the density of male and 
female gametocytes in their peripheral blood [1]. Antimalarial drugs differ in their activity against 
gametocytes [2]. Artemisinins effectively clear asexual parasites and developing gametocytes but 
have limited efficacy against mature gametocytes [3-5] and therefore do not fully prevent 
transmission after treatment [4]. Primaquine (PQ) and methylene blue (MB) are potent 
gametocytocidal compounds. For these drugs, effects on transmissibility may occur before a 
measurable impact on total gametocyte density [6]. One plausible explanation for this early 
transmission blockade would be a preferential clearance of male or female gametocytes, resulting in 
a distorted, non-viable gametocyte sex ratio [7]. Gametocytocidal drugs may indeed exert different 
effects on male and female gametocytes [2, 8] with MB preferentially clearing male gametocytes [4] 
and indications that PQ may preferentially clear female gametocytes [4]. An alternative explanation 
for early transmission blockade would be a gametocyte-sterilizing effect, a reduction in gametocyte 
infectivity in the absence of, or prior to, an effect on density. We recently presented a mathematical 
model to predict mosquito infection rates based on gametocyte density and sex ratio [1]. Here, we 
utilize this model to examine whether early transmission-blocking effects of PQ and MB can be 
explained by their effects on gametocyte density or sex ratio or whether there is evidence for a 
sterilizing effect that precedes gametocyte clearance. 
METHODS 
We used data from a previously reported single-blind, randomized controlled trial that received 
ethical approval from the University of Science, Techniques, and Technologies (Bamako, Mali), the 
University of California-San Francisco (San Franscisco, USA), and the London School of Hygiene & 
Tropical Medicine (London, UK) [4]. The trial compared sulfadoxine-pyrimethamine and amodiaquine 
(SP/AQ) and dihydroartemisinin-piperaquine (DP) as non-gametocytocidal drugs with no established 
effects on mature gametocytes, with SP/AQ plus a single dose of 0·25 mg/kg PQ (SP/AQ-PQ), and DP 
plus 15 mg/kg MB per day for 3 days (DP-MB) as gametocytocidal drug combinations [4].  Following 
written informed consent (participants ≥18 years) or parental consent (participants <18 years) with 
assent for children aged 12–17 years, asymptomatic microscopy-positive gametocyte carriers aged 5-
50 years were recruited in Ouélessébougou, Mali. Infectivity of participants to mosquitoes (the 
percentage of mosquitoes that develop oocysts) was assessed by membrane feeding assay prior to 
treatment and on days 2 and 7 after initiation of treatment. Density of male and female gametocytes 
was determined by quantitative reverse-transcription polymerase chain reaction assays targeting 
female (Pfs25) and male (PfMGET) gametocyte transcripts with sex-specific trendlines [9]. 
Comparisons of gametocyte densities were done using t-tests on log-transformed values, giving 
estimates of the ratio of geometric mean (RGM) densities of male and female gametocytes between 
treatment groups. To make log-transformation possible, zeros were imputed to 0.005 gametocytes 
per microliter (half the minimum detectible concentration). Infectivity in DP-MB and SP/AQ-PQ arms 
was compared with that of non-gametocytocidal drugs (DP or SP/AQ) using a previously published 
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statistical model, controlling for male and female gametocyte density [1]. Because of low infectivity 
following DP-MB or SP/AQ-PQ, it was not possible to estimate the relative reduction in probability of 
transmission conditional upon gametocyte density (models failed to converge). To overcome this, the 
non-parametric van Elteren’s test [10] was used; an extension of the Wilcoxon rank sum test that 
compares groups in a stratified manner. Because gametocyte density is a strong non-linear 
determinant of infectivity, we compared infectivity between groups after stratifying in categories 1, 1 
to <5, 5 to <20, 20 to <50, 50 to <100 and 100 total gametocytes per microliter. Infectivity was then 
compared within different bins to test for differences between arms, accounting for gametocytemia. 
 
RESULTS  
The study was conducted from June 27 - November 1, 2016. Samples from 80 participants were 
analysed at enrolment, day 2 and day 7 post-initiation of treatment. On day 2 there was no evidence 
that female gametocyte densities were lower following treatment with DP-MB (ratio of geometric 
mean densities (RGM) with 95% confidence interval 0.37 (0.12, 1.13) p=0.079) or SP/AQ-PQ (RGM= 
1.23 (0.39, 3.94) p=0.718) compared to non-gametocytocidal drugs (Figure 1A). Similarly, there was 
no evidence that male gametocyte densities were lower on day 2 following treatment with DP-MB 
(RGM= 0.54 (0.26, 1.09) p=0.085) or SP/AQ-PQ (RGM= 1.81 (0.95, 3.46) p=0.071) compared to non-
gametocytocidal drugs (Figure 1A). In contrast, treatment with DP-MB reduced day 7 densities of 
both female (RGM= 0.015 (0.004, 0.053) p<0.001) and male gametocytes (RGM= 0.002 (0.001, 0.007) 
p<0.001) and treatment with SP/AQ-PQ reduced day 7 densities of both female (RGM= 0.003 (0.001, 
0.010) p<0.001) and male gametocytes (RGM= 0.254 (0.082, 0.787) p=0.018) compared to non-
gametocytocidal drugs (Figure 1B).  
In a model adjusting for male and female gametocyte density, there was no evidence that among 
non-gametocytocidal arms infectivity differed between baseline and day 2 (risk ratio (RR) = 1.08 
(0.57, 2.03) p = 0.819) (Figure 1C) and between baseline and day 7 (RR = 1.51 (0.71, 3.32) p = 0.288) 
(Figure 1C). Infectivity at a given density was similar for those on SP-AQ compared to DP (RR = 0.72 
(0.36, 1.43) p = 0.345). Despite considerable overlap of gametocyte densities in all arms, infectivity 
after DP-MB and SP/AQ-PQ was substantially lower on day 2. For those on non-gametocytocidal 
drugs 22/36 (61%) were infectious to mosquitoes on day 2, compared to 0/19 (0%) on DP-MB and 
1/19 (5%) on SP/AQ-PQ, with strong evidence for lower infectivity after adjusting for gametocyte 
density (van Elteren's test p<0.001). The reduction in infectivity on day 2 was thus not explained by 
gametocyte density (Figure 1D) or sex ratio (Figure 1A). Infectivity for those on MB and PQ remained 
lower on day 7, with 19/36 (53%) on non-gametocytocidal drugs infectious to mosquitoes compared 
to 0/8 (0%) of those on MB and 0/11 (0%) of those on PQ (Figure 1D). There was less overlap in 
gametocyte densities between those on MB or PQ and those on gametocytocidal drugs but again 
there was evidence that infectivity was lower for those on gametocytocidal drugs after adjusting for 
gametocyte density (van Elteren's test p=0.044). 
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DISCUSSION 
This study found that measures of mRNA gametocyte density do not correlate with infectivity shortly 
after treatment with gametocytocidal drugs. The major implication of this finding is that studies 
examining transmission-blocking effects of drugs and potentially vaccines require mosquito-feeding 
assays to measure infectivity. Gametocytocidal drugs rapidly clear gametocytes, distort gametocyte 
sex ratio [4, 11] and prevent onward transmission to mosquitoes [4, 6, 7]. Although it was previously 
reported that the transmission-blocking effect of PQ may precede its gametocyte clearing effect [7], 
it has been unclear to what extent an early effect of sex ratio may contribute to this rapid prevention 
of onward transmission [7]. For MB we previously hypothesized that its preferential clearance of 
male gametocytes may (partially) explain its early transmission-blocking effects [4]. In the current 
manuscript, we present evidence that gametocyte density and sex ratio are unaffected in the first 48 
hours after initiation of treatment, despite a near complete prevention of onward transmission to 
mosquitoes. Non-gametocytocidal drugs did not alter the shape of the association between 
gametocyte density, sex ratio and mosquito infection prevalence; gametocytes appeared equally 
infectious before and after treatment. In contrast, gametocyte density and sex ratio no longer 
explained transmission after treatment with DP-MB or SP/AQ-PQ: gametocytes persisted with sex 
ratios similar to those before treatment but mosquito infections were nearly completely prevented. 
The mechanism underlying the early sterilizing effect despite continued presence of gametocyte 
mRNA transcripts is unclear. Whilst mRNA is unlikely to survive in free-floating form, and also by 
microscopy gametocyte densities remain unaffected shortly after treatment [6], it is possible that 
mRNA persists in red blood cells with parasites that are damaged by treatment.  Upon reaching 
maturity, gametocytes complete their preparations for onward development and maintain cell cycle 
arrest until triggered to differentiate into gametes in the mosquito. Therefore, metabolic activity of 
mature gametocytes is likely reduced to “housekeeping” functions such as ATP production and 
general redox activity. Antimalarials that cause generalised cellular damage such as oxidative stress 
induced by MB inhibition of glutathione reductase [12], may manifest an initial transmission-blocking 
effect only apparent when gametocytes re-engage the complex cellular processes required for 
successful gametogenesis. PQ is similarly postulated to operate though reactive metabolites causing 
non-specific damage to gametocytes [13]. The molecular mechanisms underlying the apparent male-
biased clearance of gametocytes after MB treatment and female-biased clearance after PQ 
treatment are currently unclear, however they likely reflect the sexual dimorphism of gametocyte 
proteomes. Our findings thus provide evidence for an early sterilizing effect of MB and PQ. Molecular 
tools to quantify male and female gametocytes cannot replace mosquito-feeding experiments to 
assess transmission-blocking properties of antimalarials. 
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Figure1. Associations between gametocyte density, sex ratio, treatment and the proportion of 
mosquitoes that develop oocysts (become infected). The association between male and female 
gametocyte density is presented for day 2 (A) and day 7 (B) post initiation of treatment. The 
association between female gametocyte density and the proportion of infected mosquitoes is 
presented for individuals receiving non-gametocytocidal drugs (C) and gametocytocidal drugs (D). In 
all panels green symbols represent observations following DP, orange SP/AQ, maroon DP-MB and 
blue SP/AQ-PQ. Crosses represent feeding outcomes from experiments conducted on day 2 post-
initiation of treatment and triangles feeding outcomes from experiments conducted on day 7 post 
initiation of treatment. In panels C and D, the proportion of mosquitoes developing oocysts prior to 
treatment are plotted in light grey circles for all treatment arms for illustrative purposes; the black 
line indicates the shape of the best fit relationship between female gametocyte density and 
infectivity in the absence of malaria treatment as previously defined [1]. 
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